-
Many hospitals will be besieged and severely overcrowded if an outbreak of severe acute respiratory syndrome (SARS) occurs during the 2003-2004 influenza season, a government watchdog agency recently warned Congress.
-
Increased reimbursement, a new nasal delivery system, and the lingering shadow of severe acute respiratory syndrome (SARS) should combine to make for a memorable 2003-2004 flu vaccination season.
-
With approximately 95% of all new HIV infections now occurring in developing countries, the search for a global AIDS vaccine is increasingly critical. Some barriers have fallen, but the virus is an elusive target, said Gary J. Nabel, MD, PhD, director of the vaccine research center at the National Institutes of Health.
-
Strep pneumo vaccine for cochlear implants urged
-
No matter what your background, there is little doubt you can quickly name several people that impacted your infection prevention experience in a positive way, making you better that day and beyond. No doubt these same memorable people made it possible for you to see your contributions as productive and meaningful, when you saw them as commonplace and ordinary. These people are mentors.
-
The Centers for Disease Control and Prevention is finalizing new guidelines on prevention of norovirus infections and was expected to release them soon as this issue went to press.
-
In this issue we conclude our two-part special report "MRSA Patient Stories" with comments from clinicians and public health officials, particularly in light of emerging data indicating MRSA infections can be sharply reduced through patient screening programs.
-
A new rapid tuberculosis test promises to help reduce health care worker exposures through early identification of patients.
-
Applying the considerable power of infection control interventions across more than 150 hospitals nationwide, the Veterans Affairs (VA) system is planning to target Clostridium difficle in its next major initiative, Hospital Infection Control & Prevention learned.
-
A universal screening program for methicillin-resistant Staphylococcus aureus (MRSA) at Loyola University Medical Center in Chicago is reducing infections by approximately 70% annually, says Jorge Parada, MD, MPH, infectious disease chief at the teaching hospital.
